8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001193125-26-421079 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement
Directly affected
- RARE Ultragenyx Pharmaceutical
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001193125-26-421079 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement
Source: sec-edgar
Ultragenyx Pharmaceutical (RARE) since “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” compared with the market
Since the first closing price after “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Ultragenyx Pharmaceutical (RARE) is -0.69%. The S&P 500 fund (SPY) is -0.67% over the same days, a -0.02% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| Ultragenyx Pharmaceutical (RARE) | that day | -0.13% | final price |
| Ultragenyx Pharmaceutical (RARE) | the next day | +1.68% | final price |
| Ultragenyx Pharmaceutical (RARE) | two days later | -2.55% | final price |
| Ultragenyx Pharmaceutical (RARE) | three days later | +1.01% | final price |
| Ultragenyx Pharmaceutical (RARE) | three days earlier | +3.75% | final price |
| Ultragenyx Pharmaceutical (RARE) | five days earlier | -0.20% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
Filings that name Ultragenyx Pharmaceutical (RARE) around 14 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)”
Companies mentioned with this story
- RARE Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical (RARE) is linked, with no stored direction, high confidence in the 14 Oct 2026 story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> RARE
How “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” reaches Ultragenyx Pharmaceutical (RARE)
The 14 Oct 2026 story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” names Ultragenyx Pharmaceutical (RARE) because of this story.
The link for Ultragenyx Pharmaceutical (RARE) is this: SEC 8-K filing -> direct issuer disclosure -> RARE
The price range for Ultragenyx Pharmaceutical (RARE), and the dates in the story
RARE traded between 12.88 and 15.73 across 11 sessions. The latest close on file is 15.07.
A simple score for Ultragenyx Pharmaceutical (RARE)
31 out of 100
“8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” scores 31 out of 100. The score uses 1 sources, a +2.48% difference versus the S&P 500 (SPY), and 1 linked companies.